Leaderboards/Prostate Cancer Treatment and Research

Prostate Cancer Treatment and Research

Last updated June 1, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Fabrice André
Inserm
99
2
Barbara Alicja Jereczek‐Fossa
University of Milan
82
3
Rosalind A. Eeles
Royal Marsden NHS Foundation Trust
81
4
Thomas Zilli
Unknown
78
5
Rajesh Thirumaran
Catholic Medical Center
75
6
Orsolya Máté
University of Pecs
70
7
Michael S. Hofman
Peter MacCallum Cancer Centre
67
8
P. Rischmann
Centre Hospitalier Universitaire de Toulouse
66
9
Eman A. Toraih
Suez Canal University
66
10
Xiuping Yu
Louisiana State University Health Sciences Center Shreveport
65

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Louise Emmett
Garvan Institute of Medical Research
99
2
James P Buteau
Peter MacCallum Cancer Centre
95
3
Silke Gillessen
Ente Ospedaliero Cantonale
89
4
David J. Einstein
Beth Israel Deaconess Medical Center
83
5
Bisheng Cheng
Beth Israel Deaconess Medical Center
83
6
Jia Yi
Nantong University
79
7
Kailai Li
Zhujiang Hospital
75
8
Sudhanshu Kumar Jha
National Institute of Ayurveda
74
9
Raghava Kashyap
University of Melbourne
72
10
Charles Parker
Royal Marsden NHS Foundation Trust
70

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
David E. Neal
University of Cambridge
99
2
Jie He
Chinese Academy of Medical Sciences & Peking Union Medical College
95
3
Matthew R. Sydes
Cancer Research UK
89
4
Johann S. de Bono
Royal Marsden NHS Foundation Trust
81
5
Per Nilsson
Skåne University Hospital
80
6
Michel P. Coleman
London School of Hygiene & Tropical Medicine
79
7
Mahesh Parmar
University College London
78
8
Lynn M. Matrisian
Pancreatic Cancer Action Network
77
9
Elżbieta Senkus
Gdańsk Medical University
77
10
Simon Chowdhury
Sarah Cannon Research Institute
70

All-Time Leaders Papers

1
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
New England Journal of Medicine|2015
2.2k cit.
2
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
The Lancet|2015
2k cit.
3
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer
New England Journal of Medicine|2020
760 cit.
4
METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer
European Urology|2016
326 cit.
5
Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic
CA A Cancer Journal for Clinicians|2011
209 cit.
6
Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial
Cancer Discovery|2021
160 cit.
7
Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance
Cell Death and Disease|2018
133 cit.
8
Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-κB/Snail pathway
Journal of Experimental & Clinical Cancer Research|2017
127 cit.
9
miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression
Carcinogenesis|2011
98 cit.
10
Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinoma
Nature Communications|2020
61 cit.

Reagents for Prostate Cancer Treatment and Research

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling Technology

Tyrosine Hydroxylase (E2L6M) Feline Chimeric Monoclonal Antibody

Cited in 14 papers
#69079$166
View Evidence →Cell Signaling Technology

Translational Control Antibody Sampler Kit

Cited in 8 papers
#9918$581
View Evidence →Cell Signaling Technology

CD45 (Intracellular Domain) (D9M8I) Rabbit Monoclonal Antibody (PE Conjugate)

Cited in 7 papers
#14579$465
View Evidence →

⭐ Recommended

Best all-around

Cell Signaling Technology

Phospho-TBK1/NAK (Ser172) (D52C2) Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

Cited in 7 papers
#14586$493
View Evidence →Cell Signaling Technology

Synaptophysin (7H12) Mouse Monoclonal Antibody (BSA and Azide Free)

Cited in 16 papers
#36451$865
View Evidence →Cell Signaling Technology

p44/42 MAPK (Erk1/2) (137F5) Rabbit Monoclonal Antibody (PE Conjugate)

Cited in 12 papers
#8867$465
View Evidence →

🌟 All-Time

Most validated

Agilent/Dako

Prostate Specific Antigen Membrane Antigen

Cited in 32 papers
#M3620
View Evidence →Cell Signaling Technology

PINCH (5G7) Mouse Monoclonal Antibody

Cited in 24 papers
#11890$158
View Evidence →Cytek Biosciences

PE Anti-Mouse CD274 (PD-L1, B7-H1) (10F.9G2)

Cited in 21 papers
#50-1243
View Evidence →